Investing.com - Collegium Pharmaceutical (NASDAQ: COLL) reported first quarter EPS of $1.32, $0.07 worse than the analyst estimate of $1.39. Revenue for the quarter came in at $144.77M versus the consensus estimate of $139.02M.
Collegium Pharmaceutical's stock price closed at $22.20. It is down -22.35% in the last 3 months and up 43.04% in the last 12 months.
Collegium Pharmaceutical saw 1 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Collegium Pharmaceutical's stock price’s past reactions to earnings here.
According to InvestingPro, Collegium Pharmaceutical's Financial Health score is "great performance".
Check out Collegium Pharmaceutical's recent earnings performance, and Collegium Pharmaceutical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar